Evidence map›Paper›PMID 37512002›Full record

ReviewMedicina (Kaunas, Lithuania)2023

Hypermagnesemia in Clinical Practice.

Aya Hasan Aal-Hamad, Abdullah M Al-Alawi, Masoud Salim Kashoub, Henrik Falhammar

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Plasma chemistry, erythrocyte, and spleen responses to fatigue and recovery in UJournal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2026
    Article
  6. Article
  7. Review
  8. Maternal and Fetal Magnesium Balance: Impacts and Implications.Advances in experimental medicine and biology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Hypermagnesemia in a psychiatric hospital.PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Aya Hasan Aal-HamadDepartment of Emergency, Sultan Qaboos University Hospital, P.O. Box 141, Muscat 123, Oman.
Abdullah M Al-AlawiDepartment of Medicine, Sultan Qaboos University Hospital, P.O. Box 141, Muscat 123, Oman.ORCID 0000-0003-2077-7186
Masoud Salim KashoubDepartment of Medicine, Sultan Qaboos University Hospital, P.O. Box 141, Muscat 123, Oman.ORCID 0000-0002-4103-8174
Henrik FalhammarDepartment of Endocrinology, QB85, Karolinska University Hospital, 17176 Stockholm, Sweden.ORCID 0000-0002-5622-6987
Oman Medical College · OMKarolinska University Hospital · SESultan Qaboos University Hospital · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypermagnesemia is a relatively uncommon but potentially life-threatening electrolyte disturbance characterized by elevated magnesium concentrations in the blood. Magnesium is a crucial mineral involved in various physiological functions, such as neuromuscular conduction, cardiac excitability, vasomotor tone, insulin metabolism, and muscular contraction. Hypomagnesemia is a prevalent electrolyte disturbance that can lead to several neuromuscular, cardiac, or nervous system disorders. Hypermagnesemia has been associated with adverse clinical outcomes, particularly in hospitalized patients. Prompt identification and management of hypermagnesemia are crucial to prevent complications, such as respiratory and cardiovascular negative outcomes, neuromuscular dysfunction, and coma. Preventing hypermagnesemia is crucial, particularly in high-risk populations, such as patients with impaired renal function or those receiving magnesium-containing medications or supplements. Clinical management of hypermagnesemia involves discontinuing magnesium-containing therapies, intravenous fluid therapy, or dialysis in severe cases. Furthermore, healthcare providers should monitor serum magnesium concentration in patients at risk of hypermagnesemia and promptly intervene if the concentration exceeds the normal range.

Indexed as

MagnesiumMetabolic DiseasesDietary SupplementsElectrolytesHumansRenal DialysisElectrolytesMagnesiumclinical practiceelectrolyte disturbancehypermagnesemiahypomagnesemiamagnesium homeostasis

Identifiers

PMID37512002
PMCPMC10384947
OpenAlexW4382136078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.